Michael J. Donovan PhD, MD

Michael J. Donovan, PhD, MD has a diverse and extensive work experience. Michael J. is currently the Chief Medical Officer at PreciseDx since January 2021. Prior to this role, they served as the Chief Clinical Officer at Vigilant Biosciences, Inc. starting from March 2016. Michael J. also worked as a Professor of Pathology at Mt. Sinai Medical Center starting from October 2011. Additionally, they held the position of Clinical Liaison at Exosome Dx starting from August 2011. Their experience includes being the CEO of PathoCon from October 2002 to March 2012. Michael J. also served as the Chief Scientific Officer (CSO) at Aureon Biosciences from February 2009 to October 2011. Michael J. held the position of scientific director at althia from 2007 to 2011. Furthermore, they were the Senior Vice President (SVP) at Aureon Laboratories from 2004 to 2008. Michael J. served as the SVP, Oncology, Pathology at Incyte Genomics from 2002 to 2003. Lastly, they held the role of Senior Director at Millennium Pharmaceuticals from 1997 to 2001.

Michael J. Donovan PhD, MD, attended Rutgers University–New Brunswick, where they pursued their education. However, specific details regarding the degree obtained and field of study are not available.